Consistent with this observation, IV BCG did not enhance tumor-specific CD8+ T cell responses in mice lacking perforin (Supplementary Fig. 8b), and splenocytes did not display enhanced cytotoxicity against B16-F10 cells in vitro (Supplementary Fig. 8c). This evidence concerns the gene PRF1 and neoplasm.